SLEEPZ AG — Earnings Release 2009

Nov 17, 2009

News Details

Ad-hoc | 17 November 2009 10:00

bmp AG: Nine-month figures for 2009

bmp AG / Quarter Results

17.11.2009

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

bmp AG: Nine-month figures for 2009

Berlin, 17 November 2009

bmp AG (ISIN DE0003304200) ended the first nine months of 2009 with sales
revenue of EUR 0.2 million (previous year: EUR 3.7 million) and a
consolidated net loss of EUR 5.6 million after a consolidated net profit of
EUR 2.1 million as of the end of the same period of the previous year.

The negative result for the quarter of EUR 3.3 million was primarily the
result of a revaluation of almost EUR 3 million on the investment in
Revotar Biopharmaceuticals AG. This was due to the failure of a financing
round that had already been internally committed, with the result that the
financing range is currently below twelve months and therefore leads to a
greater discount factor in line with bmp regulations. This financing round
is now expected to be restructured and concluded in December.

Most of our investments continued to enjoy a dynamic development. Total
financing requirements for the next twelve months are extremely low.

Marketable securities and cash and cash equivalents amounted to EUR 5.5
million as of 30 September 2009 (previous year: EUR 10.3 million). Two
investments (Vestcorp AG and Salt of Life AG) were disposed of in November
following the occurrence of suspensive conditions, leading to a slightly
positive earnings contribution from the passive portfolio: The occurrence
of the conditions will result in an inflow of liquidity of around EUR 1.3
million before the end of 2009.

A return to profitability in the fourth quarter of 2009 is realistic if
the general economic environment stabilises. Nonetheless, the Company will
end the 2009 financial year with a consolidated net loss for the first time
again following six profitable years.

The detailed nine-month report will be published on 27 November 2009 at
www.bmp.com.

---

Information and Explaination of the Issuer to this News:

For further information:

Corinna Riewe
Investor Relations

criewe@bmp.com
Phone: +49-30-20 30 5 567
Fax: +49-30-20 30 5 555

bmp AG, Schlüterstraße 38, D-10629 Berlin

http://www.bmp.com

International securities identification number (ISIN): DE0003304200

This ad hoc report represents neither an offer nor a request for an offer
for the purchase of securities to be submitted - especially not in the USA
and not in countries or jurisdictions in which an offer, a request for an
offer for the purchase of securities to be submitted or the sale of
securities would not be permitted under the prevailing Securities Law
without prior registration or listing.

This ad hoc report represents neither an offer for the sale of shares made
out to the bearer nor a request for an offer for the purchase of shares to
be submitted. It is for information purposes only.

17.11.2009 Financial News distributed by DGAP. Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: bmp AG
Schlüterstraße 38
10629 Berlin
Deutschland
Phone: +49 (0)30 20 305-0
Fax: +49 (0)30 20 305-532
E-mail: ir@bmp.com
Internet: www.bmp.com
ISIN: DE0003304200
WKN: 330420
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, München, Düsseldorf, Stuttgart, Hamburg; Foreign
Exchange(s) Warschau

End of News DGAP News-Service

---